Position in QGEN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,213,429
+$31,489 QoQ
Shares Held
31,034
+5.1% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#153
of 332 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $179,401,377 across 25 Diagnostics & Research names. QGEN ranks #19 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
109,972 | $55,135,561 | |
| 2 | DHR |
Danaher Corp /De/
|
139,533 | $26,578,245 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
117,365 | $22,677,265 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
22,840 | $12,023,889 | |
| 5 | LH |
Labcorp Holdings Inc.
|
32,320 | $9,049,600 | |
| 6 | DGX |
Quest Diagnostics Inc
|
39,616 | $8,396,611 | |
| 7 | NTRA |
Natera, Inc.
|
27,675 | $7,512,378 | |
| 8 | A |
Agilent Technologies, Inc.
|
48,741 | $6,474,267 |
All Filings in QGEN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,213,429 | 31,034 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,181,940 | 29,519 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,471,508 | 32,722 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,459,829 | 32,673 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $828,506 | 17,239 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $558,767 | 13,917 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $503,055 | 11,297 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $450,186 | 9,879 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $392,697 | 9,557 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $420,614 | 9,784 | Shares | Sole | 2024-05-24 | |
| No filing history on record for this holder in this stock. | ||||||